Page 123 - Cellular Imaging in Regenerative Medicine, Cancer and Osteoarthritis

Stabilized Sarabesin-3 for prostate imaging
21. Rauscher I, Eiber M, Maurer T (2017) [PSMA-Radioguided Surgery for Salvage Lymphadenectomy in Recurrent Prostate Cancer] 111In-PSMA-radioguided surgery beim oligometastasierten Prosta- takarzinomrezidiv. Aktuelle Urol 48:148-152.
22. Robu S, Schottelius M, Eiber M, et al (2017) Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer. J Nucl Med 58:235-242.
23. Schottelius M, Wirtz M, Eiber M, Maurer T, Wester HJ (2015) [(111)In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery. EJNMMI Res 5:68.
24. Maurer T, Weirich G, Schottelius M, et al (2015) Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer. Eur Urol 68:530-534.
25. Lymperis E, Maina-Nock T, Kaloudi A, Krenning EP, De Jong M, Nock BA (2014) Transient in vivo NEP inhibition enhances the theranostic potential of the new GRPR-antagonist [111In/177Lu]SB3 [abstract]. Eur J Nucl Med 41 (Supplement 2):S319.
26. Nock BA, Maina T, Krenning EP, de Jong M (2014) “To serve and protect”: enzyme inhibitors as radiopeptide escorts promote tumor targeting. J Nucl Med 55:121-127.
27. Roques BP, Noble F, Dauge V, Fournie-Zaluski MC, Beaumont A (1993) Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45:87- 146.
28. Marsouvanidis PJ, Melis M, de Blois E, et al (2014) In vivo enzyme inhibition improves the targeting of [177Lu]DOTA-GRP(13-27) in GRPR-positive tumors in mice. Cancer Biother Radiopharm 29:359- 367.
29. Maina T, Kaloudi A, Valverde IE, Mindt TL, Nock BA (2017) Amide-to-triazole switch vs. in vivo NEP- inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors. Nucl Med Biol 52:57-62.
30. Suda H, Aoyagi T, Takeuchi T, Umezawa H (1973) Letter: A thermolysin inhibitor produced by Actinomycetes: phospholamidon. J Antibiot (Tokyo) 26:621-623.
31. de Blois E, Chan HS, Konijnenberg M, de Zanger R, Breeman WA (2012) Effectiveness of quenchers to reduce radiolysis of (111)In- or (177)Lu-labelled methionine-containing regulatory peptides. Maintaining radiochemical purity as measured by HPLC. Curr Top Med Chem 12:2677-2685.
32. Bakker WH, Albert R, Bruns C, et al (1991) [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci 49:1583-1591.
33. Bakker WH, Krenning EP, Breeman WA, et al (1990) Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animals. J Nucl Med 31:1501-1509.
34. de Blois E, Chan HS, Breeman WA (2012) Iodination and stability of somatostatin analogues: comparison of iodination techniques. A practical overview. Curr Top Med Chem 12:2668-2676.
35. van Weerden WM, de Ridder CM, Verdaasdonk CL, et al (1996) Development of seven new human prostate tumor xenograft models and their histopathological characterization. Am J Pathol 149:1055-1062.
36. Guneyli S, Erdem CZ, Erdem LO (2016) Magnetic resonance imaging of prostate cancer. Clin Imaging 40:601-609.
37. Futterer JJ, Briganti A, De Visschere P, et al (2015) Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. Eur Urol 68:1045-1053.
38. Heimbrook DC, Saari WS, Balishin NL, et al (1991) Gastrin releasing peptide antagonists with improved potency and stability. J Med Chem 34:2102-2107.
39. Marsouvanidis PJ, Maina T, Sallegger W, Krenning EP, de Jong M, Nock BA (2013) Tumor diagnosis with new 111In-radioligands based on truncated human gastrin releasing peptide sequences: synthesis and preclinical comparison. J Med Chem 56:8579-8587.
40. Kaloudi A, Nock BA, Lymperis E, Krenning EP, de Jong M, Maina T (2016) (99m)Tc-labeled gastrins of varying peptide chain length: Distinct impact of NEP/ACE-inhibition on stability and tumor uptake in mice. Nucl Med Biol 43:347-354.
121
5